Company Active LTD

Company profile

Oxford Immunotec Limited

ERROR: The requested URL could not be retrieved

Oxford Immunotec Limited is a UK company with status active founded in 2002 based in South East England.

CRN
04516079
Founded
2002
Age
23

Overview

Legal name
OXFORD IMMUNOTEC LIMITED
Region
South East England
Registered address
143 PARK DRIVE
MILTON
ABINGDON
ENGLAND
OX14 4SE
Insolvency history
No

Latest accounts

Financial period: 2 Jan 2023 to 31 Dec 2023

FULLACCOUNTS
Turnover
Unknown
Profit / Loss
-£29,979
Employees
179

Company events

Reference milestones and recent Companies House filing stream events.

7 events
30 Sep
2026

Accounts due

Accounts Due

Next accounts due date

28 Aug
2026

Confirmation statement due

Confirmation Due

Next confirmation statement due date

14 Aug
2025

Confirmation statement filed

Confirmation

Last confirmation statement made up date

29 Dec
2024

Accounts filed

Accounts

Last accounts made up date

03 Sep
2024

Termination Secretary Company With Name Termination Date

Officers

TM02 | Transaction MzQzNDI3Mjk0NGFkaXF6a2N4

Published 03 Sep 2024 08:04

23 Aug
2024

Confirmation Statement With No Updates

Confirmation-statement

CS01 | Transaction MzQzMzI0NzYyN2FkaXF6a2N4

Published 23 Aug 2024 12:40

21 Aug
2002

Incorporated

Inception

Company registered at Companies House

Public funding

2 awards
First funded
2010
Funded years
2010, 2013
Age at first award
7 years

Projects

2013 Collaborative R&D Lead participant

T cell assay for BK virus infection in transplant patients

1 Oct 2013 to 31 Mar 2015

Awarded
£167,200
Total cost £278,668

BK virus is endemic in the UK adult population. Although it causes little or no disease in healthy people the virus is known to persist in the kidney in particular. Reactivation of the virus is linked with immune suppressive conditions and this reactivation occurs in around 20% of kidney transplant patients and can lead to significant damage to the transp...

2010 Feasibility Studies Lead participant

Evaluation of a cell separation system to simplify detection of specific immune responses to Mycobacterium tuberculosis

1 Aug 2010 to 31 Aug 2011

Awarded
£84,918
Total cost £113,224

Awaiting Public Summary

Product types

Collaborative R&D Feasibility Studies